Kate Dudek
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Cancer-related Molecular Pathways
Papers in
- Oncology 6
- CAR-T cell therapy research 3
- Cancer-related Molecular Pathways 2
-
- RNA and protein synthesis mechanisms 2
- CRISPR and Genetic Engineering 1
- Co-authors
- Anne E. Willis (9 shared papers)John Le Quesne (3 shared papers)Carolyn Jones (7 shared papers)John R. P. Knight (3 shared papers)Thomas Sbarrato (3 shared papers)Gerry Melino (2 shared papers)Alberto Marini (2 shared papers)Richard A. Knight (2 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Modern Pathology (1 paper)Current Biology (1 paper)European Journal of Medicinal Chemistry (1 paper)Biochemical Journal (1 paper)
- Partner nations
- United KingdomCanadaItaly
In The Last Decade
Kate Dudek
12 papers receiving 365 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 78
- Oncology 115
- Biotechnology 33
- Immunology 60
- Molecular Biology 196
Countries citing papers authored by Kate Dudek
This map shows the geographic impact of Kate Dudek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Dudek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Dudek more than expected).
Fields of papers citing papers by Kate Dudek
This network shows the impact of papers produced by Kate Dudek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Dudek. The network helps show where Kate Dudek may publish in the future.
Co-authors
The 25 scholars most cited alongside Kate Dudek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 112 | |
| 2 | 2017 | 84 | |
| 3 | 2017 | 45 | |
| 4 | 2012 | 35 | |
| 5 | 2018 | 27 | |
| 6 | 2016 | 24 | |
| 7 | 2018 | 14 | |
| 8 | 2013 | 9 | |
| 9 | 2019 | 8 | |
| 10 | 2019 | 7 | |
| 11 | 2017 | 2 | |
| 12 | 2014 | 1 |
About Kate Dudek
Kate Dudek is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Biotechnology and Surgery, having authored 12 papers that have together received 368 indexed citations. Recurring topics across this work include CAR-T cell therapy research (3 papers), RNA and protein synthesis mechanisms (2 papers), Cancer-related Molecular Pathways (2 papers), Cancer Research and Treatments (2 papers), Occupational and environmental lung diseases (2 papers), CRISPR and Genetic Engineering (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Cancer Research (78 citations), Oncology (115 citations), Biotechnology (33 citations), Immunology (60 citations) and Molecular Biology (196 citations). Kate Dudek has collaborated with scholars based in United Kingdom, Canada and Italy. Frequent co-authors include Anne E. Willis, John Le Quesne, Carolyn Jones, John R. P. Knight, Thomas Sbarrato, Gerry Melino, Alberto Marini, Richard A. Knight, Ivano Amelio and Rose Zamoyska. Their work appears in journals such as Proceedings of the National Academy of Sciences, Modern Pathology, Current Biology, European Journal of Medicinal Chemistry and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.